Search Results - "OʼHagan, Derek T"

Refine Results
  1. 1

    Emerging concepts in the science of vaccine adjuvants by Pulendran, Bali, S. Arunachalam, Prabhu, O’Hagan, Derek T.

    Published in Nature reviews. Drug discovery (01-06-2021)
    “…Adjuvants are vaccine components that enhance the magnitude, breadth and durability of the immune response. Following its introduction in the 1920s, alum…”
    Get full text
    Journal Article
  2. 2

    Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines by Chatzikleanthous, Despo, O’Hagan, Derek T, Adamo, Roberto

    Published in Molecular pharmaceutics (02-08-2021)
    “…Despite the many advances that have occurred in the field of vaccine adjuvants, there are still unmet needs that may enable the development of vaccines…”
    Get full text
    Journal Article
  3. 3

    Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want by HogenEsch, Harm, O’Hagan, Derek T., Fox, Christopher B.

    Published in npj vaccines (10-10-2018)
    “…Aluminum-containing adjuvants have been used for over 90 years to enhance the immune response to vaccines. Recent work has significantly advanced our…”
    Get full text
    Journal Article
  4. 4

    New generation adjuvants – From empiricism to rational design by O’Hagan, Derek T, Fox, Christopher B

    Published in Vaccine (08-06-2015)
    “…Abstract Adjuvants are an essential component of modern vaccine development. Despite many decades of development, only a few types of adjuvants are currently…”
    Get full text
    Journal Article
  5. 5

    Aluminum Adjuvants-'Back to the Future' by Laera, Donatello, HogenEsch, Harm, O'Hagan, Derek T

    Published in Pharmaceutics (01-07-2023)
    “…Aluminum-based adjuvants will continue to be a key component of currently approved and next generation vaccines, including important combination vaccines. The…”
    Get full text
    Journal Article
  6. 6

    The continued advance of vaccine adjuvants – ‘we can work it out’ by O’Hagan, Derek T., Lodaya, Rushit N., Lofano, Giuseppe

    Published in Seminars in immunology (01-08-2020)
    “…•Key technological advances have enabled the development and licensing of vaccines containing new adjuvants.•Understanding the mechanisms of action of…”
    Get full text
    Journal Article
  7. 7

    Mechanism of action of mRNA-based vaccines by Iavarone, Carlo, O'hagan, Derek T, Yu, Dong, Delahaye, Nicolas F, Ulmer, Jeffrey B

    Published in Expert review of vaccines (02-09-2017)
    “…The present review summarizes the growing body of work defining the mechanisms of action of this exciting new vaccine technology that should allow rational…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Vaccine adjuvant formulations: A pharmaceutical perspective by Brito, Luis A, Malyala, Padma, O’Hagan, Derek T

    Published in Seminars in immunology (01-04-2013)
    “…Highlights • Formulation science is unappreciated and often overlooked in vaccinology. • Vaccine formulations should be stable, reproducible, robust and…”
    Get full text
    Journal Article
  10. 10

    Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes by Calabro, Samuele, Tortoli, Marco, Baudner, Barbara C, Pacitto, Alessandra, Cortese, Mario, O’Hagan, Derek T, De Gregorio, Ennio, Seubert, Anja, Wack, Andreas

    Published in Vaccine (17-02-2011)
    “…Abstract Vaccine adjuvants such as alum and the oil-in-water emulsion MF59 are used to enhance immune responses towards pure soluble antigens, but their…”
    Get full text
    Journal Article
  11. 11

    The Adjuvants Aluminum Hydroxide and MF59 Induce Monocyte and Granulocyte Chemoattractants and Enhance Monocyte Differentiation toward Dendritic Cells by Seubert, Anja, Monaci, Elisabetta, Pizza, Mariagrazia, O'Hagan, Derek T, Wack, Andreas

    Published in The Journal of immunology (1950) (15-04-2008)
    “…Aluminum hydroxide (alum) and the oil-in-water emulsion MF59 are widely used, safe and effective adjuvants, yet their mechanism of action is poorly understood…”
    Get full text
    Journal Article
  12. 12

    Towards an evidence based approach for the development of adjuvanted vaccines by O’Hagan, Derek T, Friedland, Leonard R, Hanon, Emmanuel, Didierlaurent, Arnaud M

    Published in Current opinion in immunology (01-08-2017)
    “…•New adjuvants are typically a combination of delivery system and an immune potentiator.•A deeper understanding of innate immunity has helped the discovery of…”
    Get full text
    Journal Article
  13. 13

    The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect by Calabro, Samuele, Tritto, Elaine, Pezzotti, Annamaria, Taccone, Marianna, Muzzi, Alessandro, Bertholet, Sylvie, De Gregorio, Ennio, O’Hagan, Derek T, Baudner, Barbara, Seubert, Anja

    Published in Vaccine (18-07-2013)
    “…Highlights • We dissect the mechanism of MF59, an adjuvant used in human vaccines. • We set to identify its putative adjuvant-active ingredient(s). • Span85…”
    Get full text
    Journal Article
  14. 14

    “World in motion” – emulsion adjuvants rising to meet the pandemic challenges by O’Hagan, Derek T., van der Most, Robbert, Lodaya, Rushit N., Coccia, Margherita, Lofano, Giuseppe

    Published in npj vaccines (21-12-2021)
    “…Emulsion adjuvants such as MF59 and AS03 have been used for more than two decades as key components of licensed vaccines, with over 100 million doses…”
    Get full text
    Journal Article
  15. 15
  16. 16

    The path to a successful vaccine adjuvant – ‘The long and winding road’ by O’Hagan, Derek T., De Gregorio, Ennio

    Published in Drug discovery today (01-06-2009)
    “…New generation vaccines will increasingly comprise highly purified recombinant proteins. Unfortunately, these antigens are often poorly immunogenic. Therefore,…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Mannosylation of LNP Results in Improved Potency for Self-Amplifying RNA (SAM) Vaccines by Goswami, Roshan, Chatzikleanthous, Despo, Lou, Gustavo, Giusti, Fabiola, Bonci, Alessandra, Taccone, Marianna, Brazzoli, Michela, Gallorini, Simona, Ferlenghi, Ilaria, Berti, Francesco, O’Hagan, Derek T, Pergola, Carlo, Baudner, Barbara C, Adamo, Roberto

    Published in ACS infectious diseases (13-09-2019)
    “…Mannosylation of Lipid Nanoparticles (LNP) can potentially enhance uptake by Antigen Presenting Cells, which are highly abundant in dermal tissues, to improve…”
    Get full text
    Journal Article
  20. 20

    The droplet size of emulsion adjuvants has significant impact on their potency, due to differences in immune cell-recruitment and -activation by Shah, Ruchi R., Taccone, Marianna, Monaci, Elisabetta, Brito, Luis A., Bonci, Alessandra, O’Hagan, Derek T., Amiji, Mansoor M., Seubert, Anja

    Published in Scientific reports (08-08-2019)
    “…Self-emulsification is routinely used for oral delivery of lipophilic drugs in vivo , with the emulsion forming in vivo . We modified this technique to prepare…”
    Get full text
    Journal Article